Discovery of Anti-SARS-CoV-2 XBB.1.5 and JN.1 Variant-Specific Monoclonal Single-Domain Antibodies from a Synthetic Library. [PDF]
Tsuji I +9 more
europepmc +1 more source
Improving the solubility of single domain antibodies using VH-like hallmark residues. [PDF]
Uto Y +9 more
europepmc +1 more source
Unlocking binding properties of single-domain antibodies targeting the polymeric immunoglobulin receptor to enhance mucosal enrichment of IgG against respiratory syncytial virus. [PDF]
Liu J +18 more
europepmc +1 more source
Enteric pharmacokinetics of monomeric and multimeric camelid nanobody single-domain antibodies. [PDF]
Debatis M +9 more
europepmc +1 more source
From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodies. [PDF]
Evers A +3 more
europepmc +1 more source
Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies). [PDF]
Hurley K, Cao M, Huang H, Wang Y.
europepmc +1 more source
Demonstration of <i>in vivo</i> efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodies. [PDF]
Gardner CL +14 more
europepmc +1 more source
Developing drug-like single-domain antibodies (VHH) from in vitro libraries. [PDF]
Erasmus MF +14 more
europepmc +1 more source
Anti-InlA single-domain antibodies that inhibit the cell invasion of Listeria monocytogenes. [PDF]
Yamazaki T +8 more
europepmc +1 more source
Screening of Single-Domain Antibodies to Adeno-Associated Viruses with Cross-Serotype Specificity and a Wide pH Tolerance. [PDF]
Guo H +6 more
europepmc +1 more source

